These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19116953)

  • 1. The development and validation of a computational model to predict rat liver microsomal clearance.
    Chang C; Duignan DB; Johnson KD; Lee PH; Cowan GS; Gifford EM; Stankovic CJ; Lepsy CS; Stoner CL
    J Pharm Sci; 2009 Aug; 98(8):2857-67. PubMed ID: 19116953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of in silico models for human liver microsomal stability.
    Lee PH; Cucurull-Sanchez L; Lu J; Du YJ
    J Comput Aided Mol Des; 2007 Dec; 21(12):665-73. PubMed ID: 17599241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intrinsic clearance for prediction of human hepatic clearance.
    Chao P; Uss AS; Cheng KC
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prediction of human clearance from hepatic microsomal metabolism data.
    Obach RS
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):36-44. PubMed ID: 11727321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using open source computational tools for predicting human metabolic stability and additional absorption, distribution, metabolism, excretion, and toxicity properties.
    Gupta RR; Gifford EM; Liston T; Waller CL; Hohman M; Bunin BA; Ekins S
    Drug Metab Dispos; 2010 Nov; 38(11):2083-90. PubMed ID: 20693417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional quantitative structure activity relationship computational approaches for prediction of human in vitro intrinsic clearance.
    Ekins S; Obach RS
    J Pharmacol Exp Ther; 2000 Nov; 295(2):463-73. PubMed ID: 11046077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting human liver microsomal stability with machine learning techniques.
    Sakiyama Y; Yuki H; Moriya T; Hattori K; Suzuki M; Shimada K; Honma T
    J Mol Graph Model; 2008 Feb; 26(6):907-15. PubMed ID: 17683964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probe ADME and test hypotheses: a PATH beyond clearance in vitro-in vivo correlations in early drug discovery.
    Bell LC; Wang J
    Expert Opin Drug Metab Toxicol; 2012 Sep; 8(9):1131-55. PubMed ID: 22681474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsome composition-based model as a mechanistic tool to predict nonspecific binding of drugs in liver microsomes.
    Poulin P; Haddad S
    J Pharm Sci; 2011 Oct; 100(10):4501-17. PubMed ID: 21574165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Prediction of Human and Rat Liver Microsomal Stability via Machine Learning Methods.
    Li L; Lu Z; Liu G; Tang Y; Li W
    Chem Res Toxicol; 2022 Sep; 35(9):1614-1624. PubMed ID: 36053050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico prediction of total human plasma clearance.
    Berellini G; Waters NJ; Lombardo F
    J Chem Inf Model; 2012 Aug; 52(8):2069-78. PubMed ID: 22715914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of drug bioavailability in humans using immobilized artificial membrane phosphatidylcholine column chromatography and in vitro hepatic metabolic clearance.
    Shin BS; Yoon CH; Balthasar JP; Choi BY; Hong SH; Kim HJ; Lee JB; Hwang SW; Yoo SD
    Biomed Chromatogr; 2009 Jul; 23(7):764-9. PubMed ID: 19296531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans.
    Naritomi Y; Terashita S; Kimura S; Suzuki A; Kagayama A; Sugiyama Y
    Drug Metab Dispos; 2001 Oct; 29(10):1316-24. PubMed ID: 11560875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of in vivo disposition from in vitro systems: clearance of phenytoin and tolbutamide using rat hepatic microsomal and hepatocyte data.
    Ashforth EI; Carlile DJ; Chenery R; Houston JB
    J Pharmacol Exp Ther; 1995 Aug; 274(2):761-6. PubMed ID: 7636740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the utility of published in vitro intrinsic clearance data for prediction of in vivo clearance.
    Nagilla R; Frank KA; Jolivette LJ; Ward KW
    J Pharmacol Toxicol Methods; 2006; 53(2):106-16. PubMed ID: 16188462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances and related issues in the use of in vitro methods to predict metabolic clearance rate of new drugs].
    Zhang Q; Wang GJ
    Yao Xue Xue Bao; 2007 Oct; 42(10):1023-8. PubMed ID: 18229605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of estimated physicochemical properties as an integrated part of predicting hepatic clearance in the early drug-discovery stage: Impact of plasma and microsomal binding.
    Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
    Xenobiotica; 2009 Mar; 39(3):227-35. PubMed ID: 19280521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models.
    Siramshetty VB; Shah P; Kerns E; Nguyen K; Yu KR; Kabir M; Williams J; Neyra J; Southall N; Nguyễn ÐT; Xu X
    Sci Rep; 2020 Nov; 10(1):20713. PubMed ID: 33244000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct determination of unbound intrinsic drug clearance in the microsomal stability assay.
    Giuliano C; Jairaj M; Zafiu CM; Laufer R
    Drug Metab Dispos; 2005 Sep; 33(9):1319-24. PubMed ID: 15951446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.